section name header

Y-Site Injection Compatibility (1:1 Mixture)

Sulbactam sodium and durlobactam sodium

(Mfr: ENT)(Conc: 15 mg/mLa,b)

I

Ceftaroline fosamil

(Mfr: ALL)(Conc: 12 mg/mLb)

Remarks:

Increase in measured turbidity with subvisible particles in 30 min at 20 to 22°C

Ref:

3983